TEST FÜR IN-VITRO-TOXIZITÄTSSCREENING

European patent · EP3394258 · In force

Register entry

Publication number
EP3394258
Application number
EP16784871
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 19, 2016
Published
Oct 31, 2018
Granted
Sep 22, 2021
Protection ends at the latest
Oct 18, 2036
Next annual fee due
Oct 31, 2026
IPC classes
C12N 15/11 (2006.01)
Priority
EP 15191075 22.10.2015
EP 15191076 22.10.2015
WO PCT/EP2015/076967 18.11.2015
EP 15195198 18.11.2015
WO PCT/EP2015/076971 18.11.2015
EP 15195202 18.11.2015
WO PCT/EP2015/079915 16.12.2015
EP 16161820 23.03.2016
EP 16174974 17.06.2016
PCT application
PCT/EP2016/075060 19.10.2016
PCT publication
WO2017/067970 27.04.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Feb 21, 2025

    Holder’s address changed

    Owner
    Roche Innovation Center Copenhagen A/S, Fremtidsvej 3, 2970 Hørsholm, Denmark → RICC A/S, c/o Roche Diagnostics A/S, Flaskehalsen 17, 4., 1799 Kobenhavn V, Denmark

    Published in Swissreg on 21.02.2025

  3. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  4. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  5. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  6. Aug 3, 2022

    Change

    Published in Swissreg on 03.08.2022

  7. Sep 22, 2021

    Granted

    Published in Swissreg on 22.09.2021

Parties

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.